Sudeep Pharma Share Debuts At Rs 730 On NSE With 23% Premium, Should You Buy, Hold Or Sell?

Sudeep Pharma Share Debuts At Rs 730 On NSE With 23% Premium, Should You Buy, Hold Or Sell?

Sudeep Pharma Share Price: Shares of Sudeep Pharma made a strong debut on Friday, November 28, to list at 23 per cent premium. On NSE, shares are listed at Rs 730, with a premium of 23.10 per cent.

The three-day initial public offering (IPO) concluded on November 25.

The IPO is a mix of a fresh issue of equity shares worth Rs 95 crore and an offer for sale of nearly 1.35 crore equity shares aggregating worth Rs 800 crore by promoters, Sujit Jaysukh Bhayani, Sujeet Jaysukh Bhayani HUF, Shanil Sujit Bhayani and Avani Sujit Bhayani.

The net proceeds from the fresh issue to the tune of Rs 75.81 crore will be for capital expenditure towards procurement of machinery for its production line located at Nandesari Facility 1, Gujarat and general corporate purposes.

Sudeep Pharma is a technology-led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and is dedicated to contributing to the global healthcare ecosystem.

The company is one of the largest producers of food-grade iron phosphate for infant nutrition, clinical nutrition, and the food and beverage sectors, in terms of production capacity with a combined annual available manufacturing capacity of 72,246 metric tons, as of June 30, 2025, as per F&S report.

It has served over 1,100 customers, and has built longstanding relationships with marquee customers including Pfizer Inc, Mankind Pharma, Merck Group, Aurobindo Pharma, Cadila Pharmaceutical, IMCD Asia Pte Ltd, and Danone SA.

ICICI Securities Ltd and IIFL Capital Services are the book-running lead managers, and MUFG Intime India Pvt Ltd is the registrar of the IPO.

Swipe Left For Next Video

Disclaimer: The views and investment tips by experts in this News18.com report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions.

Source: News18
Related Posts: Sudeep Pharma IPO Last Day Sudeep Pharma IPO Kichcha Sudeep returns for 4 more seasons of Bigg Boss Kannada after quitting Kichcha Sudeep says it's hard to look at his mom's empty chair after her death Pharma companies announce direct-to-consumer sales and price cuts in US Trump unveils major drug price deals with 9 Pharma giants DIIs continue to provide strong support to markets driven by strong domestic SPARC share price jumps another 11% Anand Rathi Share IPO Listing Price Prediction Alibaba share price jumps 10% after Nvidia partnership